The Perelman School of Medicine’s Artur V. Cideciyan discussed his team’s advances in treatment for blindness in dogs, saying that “with these results, we can start working toward treating these mutations…in humans. A crystal ball is tricky, but we hope this could be [in human trials] in a couple years.”